Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajkumar Ganesan

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Blood|June 3, 2020
Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemiaChristine Tran Quang, Benedetta Zaniboni, Romain Humeau, et al.
Protein Expression and Purification|June 12, 2012
Human caspases in vitro: expression, purification and kinetic characterizationHeidi Roschitzki-Voser, Thilo Schroeder, Esther D Lenherr, et al.
Structure (London, England : 1993)|May 15, 2012
Structural and functional analysis of HtrA1 and its subdomainsCharles Eigenbrot, Mark Ultsch, Michael T Lipari, et al.
Cancer Research Communications|March 6, 2023
Conduit CAR: Redirecting CAR T-Cell Specificity with A Universal and Adaptable Bispecific Antibody PlatformM Jack Borrok, Yonghai Li, Paul B Harvilla, et al.
The Journal of Biological Chemistry|February 25, 2012
Inhibiting alternative pathway complement activation by targeting the factor D exositeKenneth J Katschke, Ping Wu, Rajkumar Ganesan, et al.
The Journal of Biological Chemistry|March 1, 2013
Mutational tail loss is an evolutionary mechanism for liberating marapsins and other type I serine proteases from transmembrane anchorsKavita Raman, Neil N Trivedi, Wilfred W Raymond, et al.
Cancer Research|October 22, 2009
Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasisWei Li, Bu-Er Wang, Paul Moran, et al.
Scientific Reports|November 29, 2022
A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3Adam Zwolak, Szeman Ruby Chan, Paul Harvilla, et al.
Biochemical and Biophysical Research Communications|August 22, 2018
Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodiesSathyadevi Venkataramani, Sarah Low, Bernd Weigle, et al.
The Journal of Biological Chemistry|August 14, 2015
Signal Transduction and Intracellular Trafficking by the Interleukin 36 ReceptorSiddhartha S Saha, Divyendu Singh, Ernest L Raymond, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Blood|June 3, 2020
Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemiaChristine Tran Quang, Benedetta Zaniboni, Romain Humeau, et al.
Protein Expression and Purification|June 12, 2012
Human caspases in vitro: expression, purification and kinetic characterizationHeidi Roschitzki-Voser, Thilo Schroeder, Esther D Lenherr, et al.
Structure (London, England : 1993)|May 15, 2012
Structural and functional analysis of HtrA1 and its subdomainsCharles Eigenbrot, Mark Ultsch, Michael T Lipari, et al.
Cancer Research Communications|March 6, 2023
Conduit CAR: Redirecting CAR T-Cell Specificity with A Universal and Adaptable Bispecific Antibody PlatformM Jack Borrok, Yonghai Li, Paul B Harvilla, et al.
The Journal of Biological Chemistry|February 25, 2012
Inhibiting alternative pathway complement activation by targeting the factor D exositeKenneth J Katschke, Ping Wu, Rajkumar Ganesan, et al.
The Journal of Biological Chemistry|March 1, 2013
Mutational tail loss is an evolutionary mechanism for liberating marapsins and other type I serine proteases from transmembrane anchorsKavita Raman, Neil N Trivedi, Wilfred W Raymond, et al.
Cancer Research|October 22, 2009
Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasisWei Li, Bu-Er Wang, Paul Moran, et al.
Scientific Reports|November 29, 2022
A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3Adam Zwolak, Szeman Ruby Chan, Paul Harvilla, et al.
Biochemical and Biophysical Research Communications|August 22, 2018
Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodiesSathyadevi Venkataramani, Sarah Low, Bernd Weigle, et al.
The Journal of Biological Chemistry|August 14, 2015
Signal Transduction and Intracellular Trafficking by the Interleukin 36 ReceptorSiddhartha S Saha, Divyendu Singh, Ernest L Raymond, et al.
Pageof 4